4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001104659-25-050116
Director acquired 75,572 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Adiumentum Capital Fund I LP · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-16 | Grant or award : show line 1 in the form | +75,572 | $6.61 | $499,531 | 1,209,395 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-16 | Grant or award : show line 2 in the form Warrants (right to buy) | +227,000 | $6.61 | $1,500,447 | 377,193 | D |
Loading xslF345X05/tm2515303-1_4seq1.xml…